SEOUL - SK Bioscience Co. announced significant gains in its third-quarter financial performance on Thursday.
According to a new release by the Yonhap News Agency, SK Bioscience's net income for the July-September quarter was 48.4 billion won (US$35.6 million), an increase of 132.9 percent from the same period a year earlier.
The company also reported an operating profit of 60.9 billion won for the quarter, up 185.3 percent from the previous year. Revenue followed suit, rising 154.6 percent to 231.8 billion won.